ALKS icon

Alkermes (ALKS)

NASDAQ

$30.08

-$0.67 (

-2.18%

)

1D
5D
1M
6M
1Y
5Y
Market closed

ALKS: $30.08 / ₿ 0.0005 BTC / 45219 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$30.75
$25.17 - $36.32
$4.97B
10.5
$30.07
$2,489,761.64
165.12M
14.98
$26.50 - $56.00
$29.94 - $30.48
Yes

What is Alkermes (ALKS)?

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

The Alkermes (ALKS) stock price has been falling

The Alkermes plc Ordinary Shares (ALKS) stock price today is $30.08, reflecting a -2.18% move since the market opened. The company’s market capitalization stands at $4.97B, with a daily trading volume of $2.49M shares. For investors tracking price trends, Alkermes plc Ordinary Shares stock has ranged between $29.94 and $30.48 today. The previous closing price was $30.75.

Get started with Alkermes (ALKS)

Ready to get started? Follow the steps below, or read our guide on how to buy Alkermes stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy ALKS

Search for ALKS in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy ALKS.

ALKS FAQs

ALKS is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

ALKS is in the Drug Manufacturers - Specialty & Generic industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Alkermes plc Ordinary Shares (ALKS) has traded between a low of $25.17 and a high of $36.32.

ALKS is in the Drug Manufacturers industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Alkermes? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
ALKS icon
ALKS

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy Alkermes in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

Top losers

Compare the worst-performing stocks of 
the day

OTRKQ icon

OTRKQ

YOTAR icon

YOTAR

CRESW icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.